{"name":"Fresenius Kabi Oncology Ltd.","slug":"fresenius-kabi-oncology-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRmhsaFVPVl9rUEtQTGNIX1hDSU9Db3NEV21ad1lkc3FvUDV6bXlBbnhhbnFmS2hqS3dyMllub0s5czlqb1ZzYm1jOEJFOWo4U0hkRGxqQVhaSm5rRGk4akQxaVVrVklweDVHMENoelVpNGdqVDlualdPWTA5ZWx4Qzh5ZmJDcHk4VHJYNkZXMzAwOV9iQUR1Rk1GSVRxNEtCTHpsTll4SGMyRE5jTmR2N01HODJOVzZ5VHZCOXJKWkFuOU9DdDc5Q0o2NFVXS01fc2wzQmU2LWlLNHRXbVdjdXJ5V25VaHQ5Uy1FMXhiRkcwXzF3WFhQTkFHR1BwWjg?oc=5","date":"2026-04-01","type":"pipeline","source":"GlobeNewswire","summary":"Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030 - GlobeNewswire","headline":"Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPM083QTZjamg3THBPWHQwWTBxSXhJMkFXRzk2Uk5aVkxDb0lFQ1JTcmVBVjZzSDRVQ29QUUpLN3hPTmxEdldud0QzX0p2V3JEMUNKbDZzWFFrb3pJQjR2U0hkY3JTOTFaeGlHS3k2QTlMdFVmeWtHTTJGRlVteVJnRXJZSUZiY1VVTndCUjFQZTc3X19nY004RzN5VVZiem1PdzZldjllRlFnbzhVSXRiY0haOA?oc=5","date":"2026-04-01","type":"pipeline","source":"Yahoo Finance","summary":"Gemcitabine Hydrochloride Market Report 2026-2030 & 2035 Featuring Strategic Analysis of Fresenius Kabi, Eli Lilly and Company, Teva Pharma, Intas Pharma, Mylan and More - Yahoo Finance","headline":"Gemcitabine Hydrochloride Market Report 2026-2030 & 2035 Featuring Strategic Analysis of Fresenius Kabi, Eli Lilly and C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQc3pQUlVaNzZmREszckt2U292SE1xdjFnZFJuczZHamhpYXlSX1RNUUE0UWRmcjBlM1FIRi0xSzEzaTFuRWpFNm9wd3Z4WEtodk10akwwZWZ1U012dUZLeU9wRG5pN1ktbktGcjBTVl9MS1BubGlRT0R5YXZpS0xUenItalZaWmIzTXJtMjNHQnJHWlJv?oc=5","date":"2025-03-27","type":"earnings","source":"Yahoo Finance","summary":"The Global Market for Paclitaxel Injections Presents an $11.17 Billion Revenue Opportunity by 2029 - Analysis of Key Players Pfizer, BMS, Fresenius Kabi Oncology, Abbott Labs, and Viatris Among Others","headline":"The Global Market for Paclitaxel Injections Presents an $11.17 Billion Revenue Opportunity by 2029 - Analysis of Key Pla","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQX0hOQWhZQWRxVU8yRHR2T2VGZ1JRaGlmXy0wTXVlc3hha1FDNms4Z0VxNXl1TU9fVHJJMU9DZ010MWx0THBqaGVuUEZtOGtkbzdDLUd0SEd1N2J5Nm5HX2NDckR1dDJLZ1ZEOUlmNlV5NXFwQnN0ME1FR2FFSGhJODJEVUpmWWJTaGs2VnBRLUFMdjcyNzZTX2REclpLNV9uQjd4dVdjd3JIRHYzWHlyZGdjdURja3c1WmFQMmJoaEZqbFNJekpSMDFFcDZtdHhreTNlbg?oc=5","date":"2024-12-17","type":"pipeline","source":"businesswire.com","summary":"Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio - businesswire.com","headline":"Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQR1RqUGRkNnpPVm9ISm9tejN1QzJGcV9yeTRJb21lX0VyX3FwczZZTW1qWU9mMU1hSW0tUk5wWTFHa1U0czVneWlqSGVFUGFTOUhTR2hTQlpkcmM1clVfTmdJMC1ERWxqQTJ5REJaSmNPZEptdnk1OVQ1dzhzMmtTbGZiaHVjM2VyeWRpUFliQTdWUUJjVXJETUUyQV9uX3Y5b1NFX281eXRPV2ZNSkFCbFMxQTlTeFNxckFwcXRCVWozV0k4?oc=5","date":"2024-10-03","type":"deal","source":"Contract Pharma","summary":"Teva, mAbxience Expand Collaboration to Include an Additional Oncology Biosimilar - Contract Pharma","headline":"Teva, mAbxience Expand Collaboration to Include an Additional Oncology Biosimilar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNa2ZZTFRSVVBKb2Z6S2pJaEJ3d0tMRzB0eG9rN1FDZjZVM0JjRkhpSmxMVm83Rk10RjUwWlVpLWZOZDZvQVIyOTlsUV8weU9tQVZNWVNHNGFNUXRKNDJiTFBiVDhseWs3b2ZxNm45UkdWX1haUmFaNkZSYk4wM2JGYTN2ZXBvV0ZyWDFOMk5ldkhXZVBKckxORW9hMkU4Yzg?oc=5","date":"2024-08-21","type":"pipeline","source":"Grand View Research","summary":"Hungary Active Pharmaceutical Ingredients Market Size & Outlook, 2030 - Grand View Research","headline":"Hungary Active Pharmaceutical Ingredients Market Size & Outlook, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQSXktMnBWQ0d1dWRzVHlZWFJjSUcwVXBQQnpIY0hLRWdTMVRDNWhhQndsWlk2ZkY0cjhHbDNSLTUzbkV0bUp6SjVRVEZCTlJWTlJlamJjOF9xOVZncXNNX3JlTzZRQ3JYWmxocHY5RUlEMkNWM2piRkt3cjJkbXpaS3Etdlp1eXdrZUd0eEFxb0psUzhkRmNpNjR0Ung?oc=5","date":"2024-08-21","type":"pipeline","source":"Grand View Research","summary":"Japan Active Pharmaceutical Ingredients Market Size & Outlook, 2030 - Grand View Research","headline":"Japan Active Pharmaceutical Ingredients Market Size & Outlook, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOWGFDdXRlUTc5R0FILUUwVS1Hd1p6ZGUzZzhqd3VJV2ZISEhScE5ING41Mk5rUmgzNFBaMk13UjByeHpkb3BYcnVHQjV1OVh3bmdpWWptS2JjZXI2anktdGo3M0o1WmVKc2dXUW54VExVTlBSTFEwOWxjRm9CLWJLSm5VVDNia1UtQ0hyYkVMUTJVSnVQOHp1SmcxRXZxV0RZWElLZHBmbFR5UQ?oc=5","date":"2024-02-28","type":"pipeline","source":"Contract Pharma","summary":"Fresenius Kabi Introduces Cyclophosphamide for Injection, USP - Contract Pharma","headline":"Fresenius Kabi Introduces Cyclophosphamide for Injection, USP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPekExZWlhaXlmNXJabTAwbnRlVkxHaFIyOTRuZDNBeU41Q205d0lPWHJJT2Z6bUt2NGF5akdUSTBwaUhKRWxoZ3hmTGdMN2J1X21lMjAyd2lyWmIwSVBQRDRJdGNvRVItT1Vod0l5S1RCUHJ3TXlwVElTbFd1MkNaZTJHb0lwLVhrNnM4YVhDckxtcGxZS29nRWt6cVZEUHRSWVpSWWk2MTliWGkxUEtONVI2YUdBNEw1dXdEenpRZWlyVjRVSHNnbHpYRUJONXRfb3RTb3F3TmVJengyWUFBOFRyQW1OaVFPQmFF?oc=5","date":"2022-05-31","type":"patent","source":"businesswire.com","summary":"Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer - businesswire.com","headline":"Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPUlZWT3BHcFU5MDl3VmxUY2hhX1lKRWZpZmxPRHp3UE1sb09OUGt2dVNUSnZMamd6MFJTZC1KQ3NDYWxiVV91bDVjc25rSmpxUlh1S2RrWmZVUk9ub1pubTZCMEdpMDNIYm9tS0xFb1FnNWhGeHVDMG96T1FvekZpQlJNa0YtRGVScWcwWEZERTBiZW50VDhWa0FYeGowT25KM2tFa1FEUHRuVVdrMERuWjB4dTZvd3puRDlJR2gwZDViMjVlX2l6a3RXVW9Ld0pYMG8xNWtJaHhBcUJQSnVTamh1UFp0NC1HeWtrWjhiVW1QZF9ZSkVTQ2lMczQ2S2dEZlZWZEhRTVA?oc=5","date":"2021-02-10","type":"pipeline","source":"NDTV","summary":"Indian Drugmaker To Pay $50 Million Fine In US For Irregularities - NDTV","headline":"Indian Drugmaker To Pay $50 Million Fine In US For Irregularities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPam5STnppWWw3SnRsc0xqLVlfbjdxYy1vaXRMWDcySXgtQkY3SDl5OWQ0RTMxQnhxd0JvUHZBMF9PdFk5NExyOXNzdWpNUm50a3dfT2V2RmhOdFZlbGl0WGN1VUNXdjEzamUwTnUtc0pCMnBZREVFSXdxQ3FnU3YySmpxRTNXUHA3Z2tJWmxOZFQ0VHFYaVRBTTJlLXhrcFVV?oc=5","date":"2017-12-28","type":"pipeline","source":"Fierce Pharma","summary":"Fresenius oncology drug plant slammed with new warning letter - Fierce Pharma","headline":"Fresenius oncology drug plant slammed with new warning letter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBNMTF3T0xxU1pvZjFlLUtXdnVnTkhNUUNmS0QwVFhOODF0cW9KWU9HT0FZaVpiVUdTSjdnTl9jRzRrSHd4dHN6UER5U3YyS0tnbG5Oc0lUdWdRd3lQNXdZYzhIeXFWVlRKNDJnaVJ4Rml1R3F3ZHNVOU02ZVI2eDg?oc=5","date":"2013-08-05","type":"patent","source":"PMLiVE","summary":"GSK loses patent on Tykerb in India - PMLiVE","headline":"GSK loses patent on Tykerb in India","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}